ATG4B and breast carcinoma: A role for ATG4B in cancer has been proposed, including chronic myeloid leukemia (Rothe et al., 2014), osteosarcoma (Akin et al., 2014), colorectal cancer (Liu et al., 2014), prostate cancer (Mouratidis et al., 2014), breast cancer (Bortnik et al., 2016) and pancreatic adenocarcinoma (Yang et al., 2018).